Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Cantor Fitzgerald Starts Associated Estates Realty (AEC) at Buy; Don't Go Changing
-
Cantor Fitzgerald Downgrades Paragon Shipping (PRGN) Two Notches to 'Sell'
-
Notable Analyst Rating Changes 01/27: (USB) (POT) (TER) Upgraded; (CLF) (TZOO) (WEN) Downgraded
-
Cantor Fitzgerald Starts Medicis (MRX) at Hold; Transitional Year Ahead; We See Some Wrinkles In The Story
-
Streetinsider.com's Hot Lunchtime Reads 01/25: (AAPL) (NOK) (ILMN) (JCP) (GM) (BAC) (JNJ)
-
Cantor Fitzgerald Maintains a 'Buy' on Waters Corp. (WAT); Solid 4Q:11 Results; Initial 2012 Guidance Is Prudently Conservative
-
Cantor Fitzgerald Maintains a 'Buy' on RF Micro Devices (RFMD); 3Q:12 In-Line; Disappointing Guidance; This Should Be the Bottom
-
Cantor Fitzgerald Maintains a 'Buy' on DHT Holdings (DHT); Continues To Shore Up Balance Sheet, Keeps Dividend
-
Dendreon (DNDN) Pushes Higher, Now Up About 6%
-
Cantor Fitzgerald Starts Oncothyreon (ONTY) at Buy; All About Stimuvax
-
Cantor Fitzgerald Starts Dendreon (DNDN) at Hold; Path to Stability
-
TVAX Biomedical (TVAX) Sees IPO Price of $9-$11/Share
-
Q4 Preview: Seasonally-Strong Year-End Quarter Could Bode Well for Intuitive Surgical (ISRG)
-
Cantor Fitzgerald Raises Price Target on Forest Laboratories (FRX) on Q3 Upside and New FY12 Guidance
-
Q2 Preview: Following Tough 2011, Analysts Optimistic on Cree (CREE)
-
Cantor Fitzgerald Reiterates a 'Sell' on First Solar (FSLR); No Change to Fundamentals
-
Goldman Sachs Downgrades Knight Capital Group (KCG) to Neutral On Competitive Threats
-
Q3 Preview: Analysts Bullish on SuperValu (SVU) into Results; Co. Beat the Last Three Quarters
-
Cantor Fitzgerald Maintains a 'Hold' on Life Technologies (LIFE); Chance to Outshine Illumina? External Validation Still Needed
-
Cantor Fitzgerald Starts Illumina (ILMN) at Hold; Sidelined Until Better Visibility
-
Cantor Fitzgerald Starts Thermo Fisher Scientific (TMO) at Buy; Leading the Way for Life Science Tools
-
Cantor Fitzgerald Starts Mettler-Toledo (MTD) at Buy; Sailing Ahead of the Pack
-
Cantor Fitzgerald Starts Life Technologies (LIFE) at Hold; Waiting for Sustainable Above-Market Growth
-
Cantor Fitzgerald Starts Waters Corp. (WAT) at Buy; Focus on Core Business Continues to Pay Off
-
CBD Energy Purchases 1.7 Million Shares from Westinghouse Solar (WEST) at $0.60/Share
-
Cantor Entertainment Technology (CETI) Files $100M IPO
-
Cantor Fitzgerald Starts Pernix Therapeutics (PTX) at Buy, Stocks Undervalued Based on Pipeline Outlook
-
Cantor Fitzgerald Starts NewLink Genetics (NLNK) at Buy; Late Stage Assets, Many Milestones
-
Cantor Fitzgerald Starts WellCare Health Plans (WCG) at Hold; Positive on Company, Shares Fairly Valued
-
Cantor Fitzgerald Starts Coventry Health Care (CVH) at Buy; Expect Increase in Enrollments and Revenues
-
Cantor Fitzgerald Starts Molina Healthcare (MOH) At Buy; Well Positioned In 2-Out-Of-3 Of Its Largest Markets
-
Cantor Fitzgerald Starts Centene (CNC) at Buy; Among the Best Positioned
-
Cantor Fitzgerald Starts AMERIGROUP (AGP) at Hold; Revenues to Surge, Earnings Could Slow
-
Cantor Fitzgerald Maintains a 'Buy' on Salix Pharmaceuticals (SLXP); Relistor News Provides Upside To Our Estimates
-
Cantor Fitzgerald Starts Acacia Research (ACTG) at Buy; The Greenest Thumb in Patent-land
-
Cantor Fitzgerald Starts CEVA Inc. (CEVA) at Buy; DSPs to the Core
-
Cantor Fitzgerald Initiates Coverage on Food Retail/Wholesale Stocks With Neutral to Negative Bias; SVU Lone 'Buy'
-
Cantor Fitzgerald Starts Kroger (KR) at Hold; Looks fairly Valued at This Time
-
Cantor Fitzgerald Starts SUPERVALU (SVU) at Buy; See Improvements Over Balance of FY:12
-
Cantor Fitzgerald Starts Sysco (SYY) at Hold; At Significant Inflection Point in Relation to Business Process Transformation Initiative
-
Cantor Fitzgerald Starts SAFEWAY (SWY) at Sell; Expect Comparisons Will Be Especially Unfavorable in FY:12
-
Cantor Fitzgerald Cuts Price Target on First Solar (FSLR) by 35%, New Outlook Reaffirms Thesis
-
Cantor Fitzgerald Starts Varian Medical (VAR) at Buy; Well Positioned to Navigate Through Troubled Waters
-
Cantor Fitzgerald Starts Hologic (HOLX) at Hold; Too Many Near-Term Challenges
-
Cantor Fitzgerald Starts Intuitive Surgical (ISRG) at Hold; High-Quality Growth, but Priced for Perfection
-
Cantor Fitzgerald Starts Conceptus (CPTS) at Buy; Better Days Are Ahead
-
Cantor Fitzgerald Starts Given Imaging (GIVN) at Buy; Keep Your Eyes on the Prize
-
Cantor Fitzgerald Starts Salix Pharmaceuticals (SLXP) at Buy; Core Business Undervalued; Pipeline Risk Remains
-
Cantor Fitzgerald Starts Ironwood Pharmaceuticals (IRWD) at Hold; The Waiting Is The Hardest Part
-
Cantor Fitzgerald Starts Forest Laboratories (FRX) at Buy; Can Forest Find Its Roots?


